Related Experiment Videos
Genetic contributors toward increased risk for ischemic heart disease
Margaret A Nordlie1, Loren E Wold, Robert A Kloner
1Division of Mathematics and Natural Sciences, University of Mary, Bismarck, ND 58504, USA.
Journal of Molecular and Cellular Cardiology
|August 10, 2005
Summary
Identifying genes linked to coronary artery disease (CAD) and myocardial infarction (MI) is crucial for developing early detection and gene therapy strategies to combat cardiovascular disease, a leading global cause of death.
Area of Science:
- Genetics and cardiovascular medicine.
Background:
- Cardiovascular disease (CVD) is a primary cause of mortality globally and in the US, incurring substantial economic costs.
- Coronary artery disease (CAD), a common form of CVD, affects millions annually, with a significant percentage experiencing myocardial infarction (MI).
- Early identification of individuals at risk for CAD is essential for implementing preventive strategies and improving treatment outcomes.
Purpose of the Study:
- To review representative studies on genes associated with increased risk for CAD and myocardial infarction (MI).
- To highlight the potential of genetic identification for early screening, prevention, and gene therapy in cardiovascular disease.
- To discuss genes involved in inherited disorders and candidate genes contributing to the multifactorial inheritance of CAD risk.
Main Methods:
- Focuses on a review of existing literature and representative studies.
- Examines genes linked to inherited disorders associated with increased CAD and MI risk.
- Investigates candidate genes potentially involved in the multifactorial inheritance of coronary heart disease (CHD) risk.
Main Results:
- The review identifies genes that predispose to or directly cause CAD.
- Studies discussed highlight the link between specific genes and an increased risk of CAD and MI.
- Candidate genes playing a role in the multifactorial inheritance of CHD risk are examined.
Conclusions:
- Identifying genes predisposing to CAD and MI is vital for advancing cardiovascular disease prevention and treatment.
- Genetic screening could enable early identification of at-risk individuals, facilitating timely interventions.
- Gene therapy holds promise for treating ischemic heart disease (IHD) and other cardiovascular conditions.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...